The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers
7 de abril de 2022 atualizado por: Derya Dağdelen, TC Erciyes University
The Effect of Planned Homecare According to Orem on the Self-care Agency and Care Burden in Patients With Primary Brain Tumors and Caregivers: A Randomized Controlled Trial
This study was conducted to evaluate the effect of home care planned according to Orem on self-care agency and care burden in brain tumor patients and their caregivers.
The study was performed with patients who underwent surgery for a brain tumor and their caregivers in the neurosurgery clinic of a tertiary hospital.
Ethical committee approval, institutional permission, patients and their caregiver verbal and written consent were obtained.
According to Orem's nursing theory, home care practice combining education, counseling and nursing care started with pre-operative education in the hospital for the patients and caregivers in the intervention group and continued at home with 5 home visits in a 6-month period.
Self-Care Agency Scale, MD Anderson Symptom Inventory Brain Tumor-Turkish Form and Caregiver Burden Scale were used as measurement tools in the study.The value of p<0.05 was accepted statistically significant in the data analyses.
Visão geral do estudo
Status
Concluído
Intervenção / Tratamento
Descrição detalhada
In this randomized controlled experimental study, it was aimed to determine the effect of home care planned according to Orem on self-care agency and care burden in brain tumor patients and their caregivers.
The study was performed with patients who underwent surgery for a brain tumor and their caregivers in the neurosurgery clinic of a tertiary hospital.
Ethical committee approval, institutional permission, patients and their caregiver verbal and written consent were obtained.
According to Orem's nursing theory, home care practice combining education, counseling and nursing care started with pre-operative education in the hospital for the patients and caregivers in the intervention group and continued at home with 5 home visits in a 6-month period.
Self-Care Agency Scale, MD Anderson Symptom Inventory Brain Tumor-Turkish Form and Caregiver Burden Scale were used as measurement tools in the study.
In addition, measurement tools used in patients and caregivers were applied to an average of 6 month: before surgery preoperative assessment at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
Data were analyzed with descriptive statistics, two-way analysis of variance.
Bonferroni correction was applied when comparing the main effects and comparisons between categorical variables and groups were evaluated with Fisher's exact test, p<.05 value was considered statistically significant.
Tipo de estudo
Intervencional
Inscrição (Real)
36
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Eyalet/Yerleşke
-
Kayseri, Eyalet/Yerleşke, Peru, 38260
- Erciyes University Faculty of Health Science
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos e mais velhos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
inclusion criteria for patient;
- living within the borders of the region,
- being over 18 years old,
- being at least literate, being able to communicate in Turkish,
- being oriented to person, place and time, not having hearing and speaking problems,
- having primar brain tumor (glial or meningeal) surgery,
- taking part in grade I, II, III
- and having Karnovsky Performance Scale (KPS) score above 50 points.
exclusion criteria for patient;
- being under the age of 18,
- illiterate, unable to communicate in Turkish,
- being diagnosed with a neurological and psychiatric disorder that may affect the cognitive status,
- not being oriented to the person, place and time, having hearing and speaking problems,
- having surgery for a metastatic brain tumor,
- having surgery for a pituitary adenoma, to have undergone emergency surgery, to have a biopsy,
- to be in grade IV,
- to have a KPS score below 50 points.
Criteria for terminating the research process;
- wanting to leave the research process,
- meeting one of the criteria for exclusion from the sample after the surgery,
- spending the home care and follow-up process in another province, and/or not being able to reach the individual.
inclusion criteria for caregiver;
- being over the age of 18,
- being literate, being able to communicate in Turkish, and not having hearing and speaking problems,
- caring for a patient who had primary brain tumor surgery.
exclusion criteria for caregiver ;
- being under the age of 18,
- illiterate, unable to communicate in Turkish,
- being diagnosed with a neurological or psychiatric disorder that may affect the cognitive status,
- and having hearing and speech problems.
Criteria for terminating the research process;
- wanting to leave the research process,
- meeting one of the criteria for exclusion from the sample after the surgery,
- spending the home care and follow-up process in another province, and/or not being able to reach the individual.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Home care group
The home care program included education, counseling and nursing care to determine and meet the self-care/dependant care needs of patients and caregivers at home after brain surgery. At preoperative period (PRP) an average of 90-120 minutes of training was given to both the patient and the caregiver until the patient was discharged. At this stage, the training was carried out in order to prepare the patient and caregiver for the transition to home. At postoperative period (POP) two home visits were made within the first month following the discharge, planned for education, counseling and nursing care. The first home visit was made in the first week after discharge (10-18 days after surgery), and the second home visit was made 30-40 days after surgery. Then, in the home visits made once in the 2nd, 3rd and 4th months.No home visits were made between the 4th-month attempt and the 6th month, but telephone counseling was provided when necessary. Home visits ranged from 60 to 120 minutes. |
home care program
|
|
Sem intervenção: Control group
The patient received routine care in the hospital until discharge.
Three home visits were made to collect the data of patients and caregivers in the 1st and 3rd and 6th months of POP after discharge, but no intervention was made.
The visits took about 30-45 minutes.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Self-Care Agency Scale (SCAS) Mean Score
Prazo: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
SCAS: in order to evaluate the self-care agency of patients and caregiver each measurement was performed before the intervention at the time.
The lowest score is 35, the highest score is 140.
The highest score shows the greatest degree of self-care agency.Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
|
MD Anderson Symptom Inventory Brain Tumor-Turkish Form (MDA-BTSETr ) Mean Score
Prazo: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
MDA-BTSETr: in order to evaluate the symptoms and the impact of the symptoms on the lives of patients, each measurement was performed before the intervention at the time.
The inventory consists of two parts that evaluate the symptoms and the interference of the individual's life.
In the first part of the inventory, individuals are asked to rate the severity of each symptom in the last 24 hours between 0-10 (0: no symptom, 10: the most severe level of the symptom experienced).
In the second part, individuals are asked to rate how much their symptoms interfere with their lives, from 0 to 10 (0: not interfered, 10: completely interfered).Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
|
Caregiver Burden Scale (CBS) Mean Score
Prazo: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
CBS: in order to evaluate the care burden of individuals who care for patients who have undergone primary brain tumor surgery, each measurement was performed before the intervention at the time.
The lowest score that can be obtained from the scale is 0, the highest score is 88, and an increasing score indicates an increase in the burden of care.Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Karnofsky Performance Scale (KPS) Mean Score
Prazo: An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
KPS allows to determine the individual and medical care needs of the patient, to obtain information about symptom severity and level of function at work and home.
It is scored between 0-100.
The loss of function from normal function (100) to death (0) based on the functional status of the individual.
Change= preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3).
and after surgery 6th month at home (Time 4).
|
An average of 6 month: preoperative assessment before surgery at hospital (Time 1), after surgery 1st month at home (Time 2) after surgery 3rd month at home (Time 3) and after surgery 6th month at home (Time 4).
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Derya Dağdelen, PhD, TC Erciyes Universty
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
6 de março de 2019
Conclusão Primária (Real)
6 de março de 2019
Conclusão do estudo (Real)
30 de julho de 2020
Datas de inscrição no estudo
Enviado pela primeira vez
6 de novembro de 2021
Enviado pela primeira vez que atendeu aos critérios de CQ
7 de abril de 2022
Primeira postagem (Real)
14 de abril de 2022
Atualizações de registro de estudo
Última Atualização Postada (Real)
14 de abril de 2022
Última atualização enviada que atendeu aos critérios de controle de qualidade
7 de abril de 2022
Última verificação
1 de abril de 2022
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2019/179
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
produto fabricado e exportado dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .